As of 2024-12-12, the Fair Value of Impel Neuropharma Inc (IMPL) is -115.47 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.24 USD, the upside of Impel Neuropharma Inc is -47,992.16%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | - | 5Y Avg | |
| Net income | -45.80 | -76.54 | -106.31 | - | -76.22 | |
| YoY growth | -9.41% | -67.12% | -38.89% | - | -38.47% | |
| Market Cap (mil) | 0.96 |
| P/E | |
| Forward P/E |
| EPS | -23.09 |
| Avg earnings growth rate | -38.47% |
| TTM earnings | -91.57 |